ITM Symposium on Actinium-225 Targeted Radionuclide Therapy at Theranostics World Congress
Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks
Thank you for your interest in ITM’s symposium“Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks” from the Theranostic World Congres 2022.
A recording of the symposium and the ensuing discussion is available to Healthcare Professionals here: View full recording
The symposium titled, “Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks” will take place on June 25, from 11:30 am to 12:55 pm CET. Participants can attend in person or join via live stream, which will be available on theTWC website ahead of the congress.
The event will feature expert speakers, Prof. Matthias Eiber, Associate Professor, Clinic and Polyclinic for Nuclear Medicine, Klinikum rechts der Isar, TU Munich, Prof. Katharina Lückerath, Preclinical Theranostics, Clinic for Nuclear Medicine, University Hospital Essen and Neil Quigley, Global Product Manager at ITM.